Get startedLog in
    Picture of Rafael Holdings logo

    RFL — Rafael Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition

    Picture of Rafael Holdings logoRafael Holdings
    11/12/2025 21:12
    Overview

Biotechnology firm's fiscal Q1 revenue rose yr/yr

Net loss increased due to Cyclo acquisition expenses

R&D expenses rose significantly after Cyclo acquisition

Outlook

Company did not provide specific financial guidance for the current quarter or fiscal year in press release

Result Drivers

INCREASED R&D EXPENSES - R&D expenses rose to $7.5 mln from $1.3 mln due to Cyclo acquisition

ACQUISITION IMPACT - Net loss increased due to Cyclo Therapeutic's expenses post-acquisition

Key Details


    MetricBeat/MissActualConsensus Estimate
    Q1 Revenue$240,000
    Q1 Net Income-$9.80 mln
    Q1 Operating Income-$10.14 mln
    

Press Release: ID:nGNX53ryVN

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

    Recent news on Rafael Holdings

    See all news